Finoriq research workspace
Arcellx, Inc. (ACLX) SEC Filings & Filing Highlights
Review SEC filings, SEC-derived company events, filing highlights, source excerpts, and material disclosure activity for Arcellx, Inc. (ACLX).
Company Snapshot
- Company
- Arcellx, Inc. (ACLX)
- Ticker
- ACLX
- Market Cap
- $6.7B
- Latest Price
- $115.01
- Industry
- Biotech & Pharma
Arcellx, Inc. (ACLX) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Arcellx, Inc. (ACLX).
| Event | Form | Date |
|---|---|---|
| The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form...The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this... | 8-K5.02 | 2026-04-28 |
| Arcellx, Inc.: Exchange listing issueIn connection with the consummation of the Transactions, the Company notified Nasdaq Stock Market LLC (“NASDAQ”) of the consummation of the... | 8-K3.01 | 2026-04-28 |
| The aggregate amount of funds used by Parent to consummate the Offer and the Merger was approxi...Pursuant to the Merger Agreement, and upon the terms and subject to the conditions described therein and in the Offer to Purchase, dated Ma... | 8-K2.01 | 2026-04-28 |
| Ashleigh Koss, MediaGILEAD SCIENCES TO ACQUIRE ARCELLX TO MAXIMIZE LONG-TERM POTENTIAL OF ANITO-CEL | 8-K7.01 | 2026-02-23 |
| Agreement and Plan of MergerOn February 22, 2026, Arcellx, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agre... | 8-K1.01 | 2026-02-23 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.